Testing new treatments for antibiotic-resistant bacterial infections in mice.
Official title: Task A94: Testing in Murine Models of Antibiotic-Resistant Bacterial Infection
Funded at Pharmacology Discovery Services Taiwan, LTD. · NIH-11178798 · Data updated 2026-11-12
This study is looking at how to better understand and treat infections caused by antibiotic-resistant bacteria using mice, which could help develop new treatments for patients who struggle with these tough infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pharmacology Discovery Services Taiwan, LTD. NIH-funded |
| Lab location | 1 site (New Taipei City, Taiwan) |
| Project start | July 10, 2024 |
| Project end | July 9, 2025 |
| Funding year | 2024 |
| Award (this year) | $503,403 |
| NIH project number | 272201700020I-0-759302400003-1 |
| Project ID | NIH-11178798 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have infections caused by antibiotic-resistant bacteria.
✕Less likely to help
Patients with infections that are not caused by antibiotic-resistant bacteria may not receive any benefit from this research.
What this research studies
This research focuses on developing and refining models to study antibiotic-resistant bacterial infections using mice. By simulating these infections, the research aims to evaluate potential new treatments and countermeasures against resistant bacteria. Patients may benefit from the findings as they could lead to more effective therapies for infections that are currently difficult to treat. The research employs advanced methodologies to ensure accurate representation of human infections in animal models.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for patients suffering from antibiotic-resistant infections.
How similar studies have gone: Other research has shown success in using animal models to develop treatments for antibiotic-resistant infections, indicating that this approach is promising.
Where this research is happening
-
Pharmacology Discovery Services Taiwan, LTD.
New Taipei City, Taiwan Active
Researchers
- Principal investigator: Miesel, Lynn — Pharmacology Discovery Services Taiwan, LTD.
- Study coordinator: Miesel, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.